413 related articles for article (PubMed ID: 29864915)
1. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells.
Yu Q; Liu Y; Wu Y; Chen Y
Biomed Pharmacother; 2018 Jul; 103():1327-1336. PubMed ID: 29864915
[TBL] [Abstract][Full Text] [Related]
2. Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells.
Liu Y; Yu Q; Chen Y
Biomed Pharmacother; 2018 Dec; 108():716-723. PubMed ID: 30248539
[TBL] [Abstract][Full Text] [Related]
3. Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells.
Liu Y; Liao L; Chen Y; Han F
Mol Med Rep; 2019 Jun; 19(6):4673-4684. PubMed ID: 30957185
[TBL] [Abstract][Full Text] [Related]
4. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
Patel TP; Rawal K; Soni S; Gupta S
Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
[TBL] [Abstract][Full Text] [Related]
5. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress.
Xie C; Chen Z; Zhang C; Xu X; Jin J; Zhan W; Han T; Wang J
Life Sci; 2016 Jul; 157():131-139. PubMed ID: 27265384
[TBL] [Abstract][Full Text] [Related]
6. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
[TBL] [Abstract][Full Text] [Related]
7. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
8. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells.
Kang OH; Kim SB; Seo YS; Joung DK; Mun SH; Choi JG; Lee YM; Kang DG; Lee HS; Kwon DY
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2578-86. PubMed ID: 24142602
[TBL] [Abstract][Full Text] [Related]
9. Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells.
Zhang J; Zhang SD; Wang P; Guo N; Wang W; Yao LP; Yang Q; Efferth T; Jiao J; Fu YJ
Eur J Pharmacol; 2019 Oct; 861():172618. PubMed ID: 31430456
[TBL] [Abstract][Full Text] [Related]
10. A diarylheptanoid compound from Alpinia officinarum Hance ameliorates high glucose-induced insulin resistance by regulating PI3K/AKT-Nrf2-GSK3β signaling pathways in HepG2 cells.
Zhang XG; Liu AX; Zhang YX; Zhou MY; Li XY; Fu MH; Pan YP; Xu J; Zhang JQ
J Ethnopharmacol; 2022 Sep; 295():115397. PubMed ID: 35605918
[TBL] [Abstract][Full Text] [Related]
11. Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling.
Zhong W; Qian K; Xiong J; Ma K; Wang A; Zou Y
Biomed Pharmacother; 2016 Oct; 83():302-313. PubMed ID: 27393927
[TBL] [Abstract][Full Text] [Related]
12. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway.
Liu Y; Xu W; Zhai T; You J; Chen Y
Acta Pharm Sin B; 2019 Jul; 9(4):745-757. PubMed ID: 31384535
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)-treated HepG2 cells.
Zhou X; Wang LL; Tang WJ; Tang B
J Ethnopharmacol; 2021 Mar; 268():113556. PubMed ID: 33157223
[TBL] [Abstract][Full Text] [Related]
14. Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes.
Wu L; Wang Y; Chi G; Shen B; Tian Y; Li Z; Han L; Zhang Q; Feng H
J Cell Physiol; 2019 Nov; 234(11):19785-19798. PubMed ID: 30937936
[TBL] [Abstract][Full Text] [Related]
15. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
[TBL] [Abstract][Full Text] [Related]
16. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
17. Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role.
Mi Y; Tan D; He Y; Zhou X; Zhou Q; Ji S
Cell Biochem Biophys; 2018 Dec; 76(4):463-470. PubMed ID: 30324559
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells.
Chen JW; Kong ZL; Tsai ML; Lo CY; Ho CT; Lai CS
J Food Drug Anal; 2018 Jul; 26(3):1075-1085. PubMed ID: 29976400
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
20. Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways.
Chen KY; Lin JA; Yao HY; Hsu AC; Tai YT; Chen JT; Hsieh MC; Shen TL; Hsu RY; Wu HT; Wang GH; Ho BY; Chen YP
Nutr Res; 2018 Apr; 52():87-97. PubMed ID: 29525610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
